Keywords: Gilead Sciences, Lupin, Patent infringement, Ranexa, Mylan, Nabumetone, Generic

Gilead files patent infringement suit against Lupin over Ranexa; Mylan’s generic nabumetone cleared by FDA

Article | 16 July 2010

Print This

Gilead Sciences says it has filed a law suit in US District Court in New Jersey, USA, against Indian-owned Lupin ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in